XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Product sales, net $ 5,624 $ 0 $ 5,624 $ 0
Operating expenses:        
Cost of sales 543 0 543 0
Research and development 10,552 2,958 36,704 13,094
Selling, general and administrative 35,196 13,353 104,665 35,381
Total operating expenses 46,291 16,311 141,912 48,475
Operating loss (40,667) (16,311) (136,288) (48,475)
Other income/(expense):        
Research and development tax credit 1,612 (309) 3,044 70
Loss on extinguishment of debt 0 0 (3,653) 0
Interest income 4,750 3,390 11,268 9,469
Interest expense (9,882) (401) (13,225) (1,434)
Foreign exchange gain/(loss) 1,475 (1,012) 1,281 660
Total other (expense)/income, net (2,045) 1,668 (1,285) 8,765
Loss before income taxes (42,712) (14,643) (137,573) (39,710)
Income tax expense (250) (44) (2,018) (527)
Net loss $ (42,962) $ (14,687) $ (139,591) $ (40,237)
Profit/(loss) per share, basic (in dollars per share) $ (0.07) $ (0.02) $ (0.22) $ (0.06)
Profit/(loss) per share, diluted (in dollars per share) $ (0.07) $ (0.02) $ (0.22) $ (0.06)
Weighted-average shares outstanding, basic (in shares) 651,944,000 638,239,000 648,633,000 631,448,000
Weighted-average shares outstanding, diluted (in shares) 651,944,000 638,239,000 648,633,000 631,448,000